India Prepares to Launch Public Vaccination Campaign against Corona

India, a country of 1.3 billion people, is likely to launch a massive vaccination campaign against coronavirus this week.

On Friday, a government committee recommended the use of the "AstraZeneca / Oxford" anti-corona virus vaccine, and the first injections may start this week after the final approval of the Indian Medicines Regulatory Authority is obtained.

The "Serum Institute of India" (Serum Institute of India), the largest producer of vaccines in the world, has stored tens of thousands of doses of the "Coffeeshield" vaccine, which was developed by "AstraZenka" in cooperation with the University of Oxford, United Kingdom (UK), and about 96,000 health care workers have been trained on Vaccinate people.

Health care workers in India have been trained in dolls at centers that were specially created for the upcoming vaccination campaign across the country.

India, the country most affected by the Coronavirus after the United States and Brazil, aspires to vaccinate about 300 million people by mid-2021.

The virus has killed 148,994 people in India, out of 10 million and 286,709 infections, according to a census conducted by Agence France-Presse, based on official sources.

The Indian Council of Medical Research expressed its optimism about the ongoing trials to reach the production of an Indian anti-virus vaccine for the novel coronavirus (known also as COVID-19), and considered them promising and attracting global attention.

A spokesman for the council  said, "The encouraging results of the trials of the first and second stage of the" Kovaxin " local vaccine have paved the way for the start of the third phase of clinical trials in India, which is taking its course in the current circumstance in 22 sites

He added that this vaccine is the result of cooperation between the Indian Council of Medical Research (ICMR)  and the Bharat Biotech Foundation.

The council stated that the data on the results of the experiments that have been completed so far have proven that the Indian vaccine "Cofaxine".